p3s-Cas9-HN Citations (5)
Originally described in: Rescue of high-specificity Cas9 variants using sgRNAs with matched 5' nucleotides.Kim S, Bae T, Hwang J, Kim JS Genome Biol. 2017 Nov 15;18(1):218. doi: 10.1186/s13059-017-1355-3. PubMed Journal
Articles Citing p3s-Cas9-HN
Articles |
---|
Purification of an Intact Human Protein Overexpressed from Its Endogenous Locus via Direct Genome Engineering. Yu J, Cho E, Choi YG, Jeong YK, Na Y, Kim JS, Cho SR, Woo JS, Bae S. ACS Synth Biol. 2020 Jul 17;9(7):1591-1598. doi: 10.1021/acssynbio.0c00090. Epub 2020 Jul 2. PubMed |
In vivo genome editing in single mammalian brain neurons through CRISPR-Cas9 and cytosine base editors. Song B, Kang CY, Han JH, Kano M, Konnerth A, Bae S. Comput Struct Biotechnol J. 2021 Apr 25;19:2477-2485. doi: 10.1016/j.csbj.2021.04.051. eCollection 2021. PubMed |
In vivo gene editing via homology-independent targeted integration for adrenoleukodystrophy treatment. Hong SA, Seo JH, Wi S, Jung ES, Yu J, Hwang GH, Yu JH, Baek A, Park S, Bae S, Cho SR. Mol Ther. 2022 Jan 5;30(1):119-129. doi: 10.1016/j.ymthe.2021.05.022. Epub 2021 May 29. PubMed |
High expression of uracil DNA glycosylase determines C to T substitution in human pluripotent stem cells. Park JC, Jang HK, Kim J, Han JH, Jung Y, Kim K, Bae S, Cha HJ. Mol Ther Nucleic Acids. 2021 Nov 29;27:175-183. doi: 10.1016/j.omtn.2021.11.023. eCollection 2022 Mar 8. PubMed |
Enhancing genome editing in hPSCs through dual inhibition of DNA damage response and repair pathways.
Park JC, Kim YJ, Hwang GH, Kang CY, Bae S, Cha HJ.
Nat Commun. 2024 May 11;15(1):4002. doi: 10.1038/s41467-024-48111-9.
PubMed
Associated Plasmids |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.